🇺🇸 Imotun in United States

9 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Acute Kidney Injury — 1 report (11.11%)
  2. Asthenia — 1 report (11.11%)
  3. Blood Glucose Increased — 1 report (11.11%)
  4. Bronchitis — 1 report (11.11%)
  5. Decreased Appetite — 1 report (11.11%)
  6. Dermoid Cyst — 1 report (11.11%)
  7. Intracranial Aneurysm — 1 report (11.11%)
  8. Red Blood Cell Sedimentation Rate Increased — 1 report (11.11%)
  9. Vitamin D Deficiency — 1 report (11.11%)

Source database →

Imotun in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Imotun approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Imotun in United States?

Chong Kun Dang Pharmaceutical is the originator. The local marketing authorisation holder may differ — check the official source linked above.